RARA CRAFT DATABASE for FDA Medical Devices
510(k)K172307

FDA DEVICE FACTS

Dynamic Coronary Roadmap 2.0

Philips Medical Systems Nederland B.V.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATEOctober 24, 2017PRODUCT CODEOWB

Indications for use

Dynamic Coronary Roadmap 2.0 , provided as accessory to the Philips Interventional X-ray system, has the following indications for use: Dynamic Coronary Roadmap is intended to assist the physician during percutaneous coronary interventions in correlating the device position to the coronary vasculature, by providing a motion compensated overlay of this coronary vasculature.

The FFR / iFR Roadmap feature is intended to assist the physician during percutaneous coronary interventions in relating the intravascular blood pressure measurement to its anatom ical location. FFR / iFR roadmap visualizes the position of the pressure wire and the coronary artery on an X- ray image at the moment that an intravascular blood pressure measurement was performed as well as the intravascular blood pressure measurement values themselves. Dynamic Coronary Roadmap is suitable for use with the entire adult human population.

The indications for use of Dynamic Coronary Roadmap 2.0 are similar to the indications for use of the currently marketed predicate device Dynamic Coronary Roadmap 1.0 (K170130). Both devices are o indicated to assist the physician during percutaneous coronary interventions in correlating the device position to the coronary vasculature, by providing a motion compensated overlay of this coronary vasculature; and o suitable for use with the entire adult human population.

The only difference is that the Indications for U se of Dynamic Coronary Roadmap 2.0 has been further detailed by adding a description of the FFR / iFR Roadmap feature. The further detailing does not raise any new safety and effectiveness questions since Dynamic Coronary Roadmap 2.0 still has the same intended use as the

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 28, 2026